Prostate cancer vaccine: Vaccitech
Latest Information Update: 24 Oct 2016
At a glance
- Originator Vaccitech
- Class Cancer vaccines; Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Prostate cancer
Most Recent Events
- 10 May 2016 Phase-I/II clinical trials in Prostate cancer in United Kingdom (Parenteral)